Senior insider sale
Chief Science Officer at NOVOCURE LTD — senior position signals high conviction
$103.3K
7.46K shares
What this filing means
WEINBERG URI plans to sell 7.46K shares of NOVOCURE LTD valued at approximately $103.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/27/2026ACC: 0001950047-26-001890
Officer· Chief Science Officer
Since Apr 2020
7.46K
Shares to sell
$103.3K
Approx. market value
7.46K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock
Not Applicable
2/27/2026
7.46KTotal acquired7.46K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/27/2026 | Restricted Stock Not Applicable | 7.46K | — |
| Total | 7.46K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
7.46K
Market value
$103.3K
2/27/2026
Total
Units
7.46K
Value
$103.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
2/27/2026 | 7.46K | $103.3K | NASDAQ | Planned |
| Total | 7.46K | $103.3K | ||